RE:RE:RE:Bids piling up. What we really need is patience. Meaningful Clinical data - whether from UHN or Buffalo - might not be presented until the middle of next year.
At present there is no hope value in the stock - i.e. if you believe in the science the current share price bears no relation to the potential here.
It has always been this way but the unexplained shambles at the beginning of Phase II made sure that it remains so.